New Delhi: Drug company Lupine on Friday said it has received approval from the US health regulator to market a generic drug to treat seizures.The company has received approval from the US Food and Drug Administration (USFDA) to market Topiramate extended-release capsules in the US, the drug...
PNNMumbai (Maharashtra) [India], June 29: Lupine Limited, in association with the Indian Society of Hypertension (ISH) and the World Hypertension League (WHL), recently carried out a blood pressure screening and awareness campaign to Nacional level. The campaign, which began on May 17 on the...
New Delhi, drugmaker Lupine and a unit of Aurobindo Pharma are recalling products from the US market due to manufacturing issues, according to the US health regulator.According to the latest Compliance Report issued by the US Food and Drug Administration (USFDA), a US-based unit of Lupine is...
New Delhi, Pharma major Lupine Ltd on Monday announced the appointment of Abdelaziz Toumi as the Chief Executive Officer of its newly formed subsidiary Lupine Manufacturing Solutions.Lupine said in a regulatory filing that Toumi is an experienced leader with a blend of scientific and...
New Delhi [India], Global pharmaceutical company Lupine Ltd said the United States Food and Drug Administration (FDA) has completed the inspection of its injectable facility in Nagpur.According to a stock market filing with the National Stock Exchange, Lupine says the US FDA conducted the...
New Delhi: Drug company Lupine is recalling more than 51,000 bottles of a generic antibiotic drug from the US market due to a "defective container", according to the US health regulator.The US-based arm of the drugmaker is recalling 51,006 bottles of Cefdinir for Oral Suspension (250 mg/5 mL)...
New Delhi: Drug maker Lupine on Wednesday said its European arm has completed the acquisition of two brands from Sanofi.Lupine Atlantis Holdings SA has completed the acquisition of Arane in Germany and Nalcrom in Canada and the Netherlands as well as the trademark rights related to Sanofi, the...
New Delhi: Drug maker Lupine on Monday said it has launched a generic drug used to treat or prevent bacterial infections in the US market.The company has launched Doxycycline for Injection USP (100 single-dose vials) in the US following approval from the US Food and Drug Administration...
New Delhi, Pharma major Lupine Ltd on Thursday announced the appointment of former Pfizer Chairman and CEO, Jeffrey Kindler and Alfonso 'Chito' Zulueta as independent directors to its board.Lupine said in a regulatory filing that Kindler is currently the CEO of Centrexion Therapeutics, a...
New Delhi: Drug firm Lupine on Monday reported a 52 per cent rise in net profit at Rs 359 crore in the March quarter.The Mumbai-based drugmaker reported a net profit of Rs 236 crore in the January-March quarter of financial year 2022-23.Total revenue from operations increased to Rs 4,961...
According to the latest enforcement report by the US Food and Drug Administration (USFDA), Cipla's subsidiary in New Jersey is recalling 59,24 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution.The reason for recalling the affected lots of Cipla products is “Short Fill”...
New Delhi: Drug firm Lupine on Friday said it has launched its first biosimilar product in Canada.The company has introduced Rimty through its partner Sandoz Canada, the Mumbai-based drugmaker said in a statement.Rimty is indicated for the treatment of moderate to severe active rheumatoid...
New Delhi: Drug maker Lupine on Thursday said it has received approval from the US health regulator to market a generic drug to treat certain eye problems.The company has received approval from the US Food and Drug Administration (USFDA) to market Etabonate Ophthalmic Suspension, the...
New Delhi: Drugmaker Lupine on Monday said it has launched Mirabegro extended-release tablets (25 mg) in the US market.Lupine said in a statement that the Mumbai-based drugmaker has launched the drug after receiving approval from the US Food and Drug Administration (USFDA).It said the...
New Delhi: Drug maker Lupine on Wednesday said it has launched the generic version of Oracea capsules in the US market.The company said it has launched the drug to treat inflammatory lesions (papules and pustules) of rosacea following approval from the US Food and Drug Administration (USFDA)...
New Delhi: Drug company Lupine on Monday said it has received approval from the UK health regulator to market a generic drug for the treatment of involuntary movements caused by tardive dyskinesia.The company has received approval from the US Food and Drug Administration (USFDA) to market...